Showcasing Tissue Regenix Group PLC on Upcoming Episode of Innovations TV Series

DMG Productions uncovers the latest advancements in regenerative medicine and cardiac treatments.

York, England —Tissue Regenix Group (TRG), announced today that it will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing via Discovery Channel 1st QT 2016. Dates and show times TBA.

Tissue Regenix Group (TRG) is a pioneering, international medical technology company, leading the development of a range of regenerative products to make specialized replacement tissue using biological (human & animal) materials.

In this segment, Innovations will explore Tissue Regenix’s dCELL® technology, a process that takes animal and human tissue and removes the cells, leaving intact an acellular scaffold that can be implanted into the body. Tissues treated with the dCELL® process deliver a highly biocompatible product removing the risk of rejection by the patient’s body, and allowing like for like tissue to be regenerated.

Viewers will learn about this unique technology and a cardiac project in Brazil in which over 1400 patients, among them 500 children to date, have benefitted from the dCELL® heart valve implant.

“We are very excited to share the dCELL® story with the Innovations viewers. With the changing needs and expectations of an increasing and aging population, dCELL® has the potential to change the landscape of modern medicine and address these growing unmet clinical needs. The dCELL® technology platform allows a new regenerative approach to the treatment of conditions such as heart valve disease and chronic woundcare, by eliminating the risk of rejection it allows the patient to return to a normal quality of life. We are still at an early stage investigating the full clinical potential of this technology, and the next decade will almost certainly see new applications developed,” said Antony Odell, CEO, Tissue Regenix Group.

“Tissue Regenix applies this technology to heart valves for the treatment of pediatric heart valve disease, which is a major problem in regions such as Brazil,” said Michele Nehls, Producer for the Innovations TV series. “This treatment has major benefits to the patient. We look forward to educating our audiences about this groundbreaking new technology.”

About Tissue Regenix Group:
Tissue Regenix is a leading medical devices company in the field of regenerative medicine. The company’s patented decellularisation (‘dCELL®’) technology removes DNA and other cellular material from animal and human tissue leaving an acellular tissue scaffold which is not rejected by the patient’s body which can then be used to repair diseased or worn out body parts. The potential applications of this process are diverse and address many critical clinical needs such as heart valve replacement, woundcare and knee repair.

Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds. The company commercialises academic research conducted by our partners around the World.

In November 2012 Tissue Regenix Group plc set up a subsidiary company in the United States- ‘Tissue Regenix Wound Care Inc.’, as part of its commercialisation strategy for its dCELL® technology platform.

For more information, visit:

About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.

DMG Productions (responsible for creating the Innovations show) includes personnel specialized in various fields from agriculture to medicine, independent films to regional news and more. Field producers work closely with experts in the field to develop stories. This powerful force enables DMG to consistently produce commercial-free, educational programming that both viewers and networks depend on.

For more information visit: or contact Michele Nehls at (866) 496-4065 x 822 or via email at [email protected]

Leave a Reply